Eupraxia Employee Directory

Eupraxia corporate office is located in 2198 Yukon St, Vancouver, British Columbia, V5Y 3P1, Canada and has 11-50 employees.

Likely to Engage tag.Highly Engaged Employees

Employees by Department

Departments

Number of employees

Engineering & Technical

7

Operations

6

Finance

4

Sales

2

C-Suite

1

Information Technology

1

Human Resources

1

Key Employees of Eupraxia

  • AR
    Canada flag for contact location.
    Alex Rothwell

    Chief Financial Officer

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Eupraxia Global Presence

globalPresence illustration
North America11-50

Index of contact profiles from Eupraxia

Hundreds of professionals searching for Eupraxia have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at Eupraxia

Explore people who held key positions, contributed to Eupraxia's success, and advanced their careers.

People from Similar Companies in the Business Services Industry Located in Canada

Frequently Asked Questions Regarding Eupraxia Employees

How many employees does Eupraxia have?
Eupraxia has 11-50 employees
Who is the CFO of Eupraxia?
Eupraxia’s CFO is Alex Rothwell
Who are Eupraxia key employees?
Some of Eupraxia key employees are Alex Rothwell
Where is Eupraxia located?
Eupraxia’s headquarters are located at 2198 Yukon St, Vancouver, British Columbia, V5Y 3P1, Canada
How do I contact Eupraxia?
Eupraxia Contact Info: Phone number: (250) 590-3968 Website: www.eupraxiapharma.com
What does Eupraxia do?

Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidates are EP-104IAR, which is in a Phase III clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis; EP-... 104GI, which is in a Phase II clinical trial for the treatment of eosinophilic esophagitis; and EP-104, under preclinical studies for the treatment of other inflammatory joint conditions, benign structures of the esophagus, and epidural delivery. It also is involved in the development of product candidates for oncology. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc.Read More

Is Eupraxia a public company?
Yes, Eupraxia is a public company and is traded under the symbol EPRX
See more information about Eupraxia Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.